Merck & Co. (MRK)
(Delayed Data from NYSE)
$102.92 USD
+1.75 (1.73%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $103.13 +0.21 (0.20%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth F Momentum D VGM
Price, Consensus and EPS Surprise
MRK 102.92 +1.75(1.73%)
Will MRK be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for MRK based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MRK
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
Moderna Stock Rises on Q3 Earnings & Sales Beat, Reiterates View
MRK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stocks and ETFs in Focus as Americans Head to Polls
Should Moderna Stock Be in Your Portfolio Pre-Q3 Earnings?
Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY's Q3 Earnings in Focus
Other News for MRK
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
Geron: A Post Earnings And Funding Announcement Assessment
Merck: An Undervalued Dividend Machine
Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom
Merck price target lowered to $140 from $145 at Deutsche Bank